Patients whose tumours possessed increased levels of DSC2 sustained a shorter disease-free survival period in comparison to patients with low DSC2 expression (all bands: p = 0.049 and upper band: p = 0.157 Fig. 2D and G). The gene discussed is DSC2; the disease is neoplasm.